Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: Intravenous tacrolimus is a superior induction therapy for acute severe ulcerative colitis compared to oral tacrolimus

Fig. 2

Efficacy of tacrolimus. a Response rates. Response rates of both tacrolimus groups exceeded 50% at 1 week with no significant differences were detected at 1 or 2 weeks. b Remission rates. Remission rates at 2 weeks after oral and intravenous tacrolimus administration were 23% and 46%, respectively. Intravenous tacrolimus was significantly superior to oral administration at 2 weeks (p = 0.04)

Back to article page